2026년 2월 9일 · Unknown · financial · 출처 Globenewswire
Chicago, Feb. 09, 2026 (GLOBE NEWSWIRE) -- The global biohacking market size was valued at USD 38.05 billion in 2025 and is projected to hit the market valuation of USD 216.68 billion by 2035 at a CAGR of 19% during the forecast period 2026–2035.
Biohacking market’s outlook is strong because the category is shifting from hype to measurable, subscription driven health utilities anchored in continuous sensing, coaching, and outcomes oriented workflows. For instance, Ōura reported revenue above 500 million dollars in 2024 and stated it was on track to reach 1 billion in sales in 2025, showing mainstream willingness to pay for passive, always on biometrics plus recurring software value.
Request Sample Pages: https://www.astuteanalytica.com/request-sample/biohacking-market
In India, Ultrahuman disclosed about 74.5 million dollars revenue in calendar year 2024, with Ring AIR contributing about 90% and a clear channel mix shift toward retail, signaling offline scalability beyond early adopter direct to consumer. Moreover, Ultrahuman also scaled manufacturing capacity sharply, added a Texas facility, and grew women users to nearly 50% by adding cycle and ovulation features, a granular indicator that “biohacking” demand is broadening into life stage specific health management.
On the metabolic side, Levels, one of the major players in the biohacking market, said it had served more than 60,000 members and amassed hundreds of millions of glucose data points, implying a data flywheel where individualized responses to food and lifestyle can be productized into higher value coaching and research partnerships.
Key Market Highlights
North America led the market with the highest revenue share of 40.5% in 2025.In terms of product, the wearables category captured the largest market share at 22.75% in 2025.For applications, the monitoring segment generated over 30.25% of the revenue share in 2025.Among end-users, the research & academic institutes represented more than 35% of the revenue share in 2025
By Prodcut, Wearables Holds the Largest 22.75% Market Share as it Fuel Record Fitness and Hypertension Insights
The wearables segment commands the biohacking market by delivering clinical-grade diagnostics directly to consumers, evidenced by Garmin’s financial surge in late 2025. Garmin reported a record $1.77 billion in Q3 2025 revenue, driven largely by a 30% growth in its Fitness segment which reached USD 333.3 million in 2025, proving that consumers are increasingly investing in neuro-wearables to optimize cognitive longevity alongside physical health.
Such financials underscore wearables' edge over implants or supplements—they provide real-time, non-invasive data fueling personalized biohacking protocols. Garmin's success mirrors broader 2025 shifts where fitness wearables evolved into multi-omics platforms, blending ECG, SpO2, and AI-driven longevity scores.
This dominance persists despite competition, as scalability and direct-to-consumer access outpace specialized alternatives.
By Application, Monitoring Segment Thrives on Direct Consumer Diagnostics as it Control Over 30% Revenue Share
Generating over 30% of biohacking market revenue, the monitoring segment is rapidly expanding as diagnostic giants pivot toward consumer-centric longevity testing. Labcorp exemplified this trend, reporting USD 14.05 billion, reflecting a market-wide surge in proactive health management. The segment's vitality is further underscored by Labcorp’s Biopharma laboratory services, which posted a 10.4% sales increase in 2025, driven by accelerated development of precision therapies.
Meanwhile, niche players like Viome continued to capture specialized market share, with its online store generating approximately $432,000 in monthly revenue by November 2025, outperforming competitors in the microbiome space. These figures confirm that deep-dive biological data has become the most valuable currency for health-conscious consumers.
By End Users, Research and Academic institutes Maintains the Market Lead
As of 2025, the dominance of research and academic institutes—commanding over 35% of the biohacking market revenue—is shaped by their evolution from passive observers to active Bio-Foundries. Unlike the previous decade's "garage biology" era, the regulatory crackdown on DIY gene editing has forced innovation back into university labs. These institutes have capitalized on this by leasing their "Level 4" safety environments and wet-lab infrastructure to bio-startups and citizen scientists. By becoming the landlord of the "hard biohacking" ecosystem (CRISPR, viral vectors, and implant prototyping), they effectively tax the entire innovation pipeline. They are no longer just grant recipients; they are commercial incubators where every breakthrough in synthetic biology generates direct licensing revenue and equity stakes for the institute.
Furthermore, this financial leadership is cemented by their monopoly on Biological Ground Truth. While tech giants possess the AI to analyze health data, academic institutes own the "raw material"—decades of longitudinal genomic and phenotypic data from diverse patient cohorts. In 2025, the most lucrative biohacking product is not a device, but the datasets required to train predictive health algorithms. Institutes are aggressively monetizing these data vaults through exclusive "Data-IP" partnerships with pharmaceutical and tech conglomerates. This high-margin licensing model ensures that even when a consumer buys a third-party wearable, a significant fraction of that value flows back to the academic institute that owned the foundational data and biological IP.
Proactive Biology Engineering Driving Biohacking Market Expansion
The trajectory of the Biohacking market has shifted dramatically in 2025, moving from experimental fringe science to a structured industry dominated by precision data. The demand is no longer driven solely by fitness enthusiasts but by a broader population seek…